๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Small Cell Carcinoma of the Bladder

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors NCT07278479Phase 1, Phase 28 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Chicago Molecular Partners AG ยท Tests: [212Pb]Pb-MP0712, [203Pb]Pb-MP0712 A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites๐Ÿ“ Goodyear๐Ÿ“ Phoenix๐Ÿ“ Duarte IDEAYA Biosciences ยท Tests: IDE892, IDE397 Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... NCT06161532Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Sacituzumab govitecan, Atezolizumab 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: [18F]FAPI-74, [18F]FDG Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767NA13 sites๐Ÿ“ Anderlecht๐Ÿ“ Ghent๐Ÿ“ Wilrijk European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: Stereotactic body radiotherapy, Palliative RT Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer NCT05312671Phase 22 sites๐Ÿ“ Washington D.C.๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Atezolizumab, Carboplatin, Cisplatin, Etoposide, Cystectomy Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) NCT07327489n/a8 sites๐Ÿ“ Fort Smith๐Ÿ“ Frederick๐Ÿ“ Springfield Elephas ยท Tests: Biopsy Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites๐Ÿ“ Greenwood Village๐Ÿ“ Manchester๐Ÿ“ Daytona Beach University of Nebraska A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites๐Ÿ“ Sacramento๐Ÿ“ Celebration๐Ÿ“ Miami Marengo Therapeutics, Inc. ยท Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors NCT07030257Phase 1, Phase 213 sites๐Ÿ“ Denver๐Ÿ“ Orlando๐Ÿ“ Grand Rapids Tasca Therapeutics ยท Tests: CP-383 ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation NCT05059444n/a57 sites๐Ÿ“ Birmingham๐Ÿ“ Chandler๐Ÿ“ Hot Springs Guardant Health, Inc. ยท Tests: Guardant Reveal A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470Phase 112 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Lake Success MacroGenics ยท Tests: MGC026 Dose Escalation, MGC026 Dose for Expansion A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies NCT04923178n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors NCT07020117Phase 114 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ Miami Aktis Oncology, Inc. ยท Tests: [225Ac]Ac-AKY-1189 (therapeutic), [64Cu]Cu-AKY-1189 (imaging) DK222 Study at Hopkins NCT07140315Phase 11 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: [18F]DK222 radiotracer Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER) NCT06228066Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Lurbinectedin, Avelumab Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors NCT05706129Phase 1, Phase 210 sites๐Ÿ“ Melbourne๐Ÿ“ Sydney๐Ÿ“ Clermont-Ferrand Lumara Bio Oncologics GmbH ยท Tests: [68Ga]Ga-DPI-4452, [177Lu]Lu-DPI-4452 The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) NCT04585750Phase 1, Phase 276 sites๐Ÿ“ Irvine๐Ÿ“ La Jolla๐Ÿ“ Los Angeles PMV Pharmaceuticals, Inc ยท Tests: rezatapopt, pembrolizumab Quantifying Systemic Immunosuppression to Personalize Cancer Therapy NCT05621837n/a1 site๐Ÿ“ Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano ยท Tests: MDSC quantification Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors NCT03866382Phase 2582 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Anchorage National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Bone Scan, Cabozantinib S-malate, Computed Tomography, Echocardiography Test Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors NCT07660055Phase 15 sites๐Ÿ“ Omaha๐Ÿ“ Darlinghurst๐Ÿ“ Montreal Novartis Pharmaceuticals ยท Tests: [68Ga]Ga-DWJ155, [177Lu]Lu-DWJ155 Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer. NCT05102110n/a1 site๐Ÿ“ Exeter Origin Sciences ยท Tests: Oricol Test A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors NCT07090499Phase 131 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ Los Angeles Pfizer ยท Tests: PF-08046876, Pembrolizumab, Cisplatin, Carboplatin Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496Phase 1, Phase 23 sites๐Ÿ“ Gilbert๐Ÿ“ Tucson๐Ÿ“ Seattle University of Arizona ยท Tests: Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Scottsdale Massive Bio, Inc. ยท Tests: Clinical Trial Matching A Study of Sigvotatug Vedotin in Advanced Solid Tumors NCT04389632Phase 1158 sites๐Ÿ“ Anchorage๐Ÿ“ Fayetteville๐Ÿ“ Rogers Seagen, a wholly owned subsidiary of Pfizer ยท Tests: sigvotatug vedotin, pembrolizumab, cisplatin, carboplatin A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871Phase 153 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Aurora Iambic Therapeutics, Inc ยท Tests: IAM1363 Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease NCT06529822Phase 13 sites๐Ÿ“ Orlando๐Ÿ“ St Louis๐Ÿ“ Columbus Washington University School of Medicine ยท Tests: Synthetic long peptide personalized cancer vaccine, Poly ICLC, Signatera or Altera testing DESTINY-PANTUMOUR04 NCT07124000n/a18 sites๐Ÿ“ Birmingham๐Ÿ“ Bullhead City๐Ÿ“ Casa Grande AstraZeneca ยท Tests: Trastuzumab deruxtecan
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy